Sales and Marketing

Showing 15 posts of 11527 posts found.

Pressure on pharma M&A

January 7, 2013 Research and Development, Sales and Marketing Ernst & Young, M&A, MA, mergers

The world’s largest pharma companies will be under greater pressure to merge with or purchase other firms over the next …

New price and data changes NICE view on Lucentis

January 4, 2013 Sales and Marketing Bayer, Eylea, Lucentis, NICE, Novartis

A new lower price and new data analysis has persuaded NICE to recommend Lucentis for patients with diabetic macular oedema …

Celgene appoints new Human Resources director

January 2, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

Celgene has announced the appointment of Sarah Bater as director of Human Resources, Celgene UK and Ireland. Bater brings a wealth …

Merck KGaA pipeline hit

December 21, 2012 Research and Development, Sales and Marketing Cancer, Merck KGaA, NSCLC, pipeline

Merck KGaA’s pipeline has been dented by the ‘disappointing’ late-stage failure of Stimuvax in a programme with non-small cell lung …

NHS blueprint under fire

December 20, 2012 Sales and Marketing CB, CCGs, Labour, NHS

The NHS Commissioning Board’s blueprint for care has promised extra funds for health providers and greater transparency for patients. Board …

Sanofi global operations president to retire

December 20, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanspeter Spek, Sanofi

Sanofi has announced that Hanspeter Spek, president, Global Operations, will retire from his current role in mid-2013. Christopher Viehbacher, chief executive …

Mixed response to ‘seven-day’ NHS

December 20, 2012 Sales and Marketing BMA, CCGs, NHS, RCP

The NHS’s possible move to seven-day working has received a mixed welcome, with the BMA dubbing the proposals ‘too crude’. …

$700m fines for Amgen

December 20, 2012 Manufacturing and Production, Sales and Marketing Amgen, FDA, off label, off-label

Amgen has pleaded guilty to misbranding its anaemia drug Aranesp following a string of US lawsuits against the biotech company. The …

NICE publishes formulary guidance

December 19, 2012 Sales and Marketing ABPI, NHS, NICE, formularies, formulary

NICE has published its first guidance on good practice for those involved in working out what medicines should be made …

Sanofi – aiming for number one in the world’s biggest diabetes market

December 18, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, Sanofi, diabetes, obesity

Sanofi is no different from any other major pharma company in seeing China as the single most important growth market …

Reports back doctor contract changes

December 18, 2012 Sales and Marketing BMA, DDRB, NHS, doctors, reform

The government looks to be heading towards a showdown with clinician groups over proposed changes to doctors’ contracts. It has …

David Haslam confirmed as NICE chair

December 18, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Haslam, Hunt, NICE

David Haslam has been confirmed as chair of the National Institute for Health and Clinical Excellence. Professor Haslam is currently …

Perjeta recommended in EU

December 18, 2012 Sales and Marketing CHMP, Cancer, Perjeta, Roche

Roche’s breast cancer treatment Perjeta has been given the thumbs up by the CHMP, paving the way for its approval …

CHMP turns down Kynamro

December 17, 2012 Sales and Marketing CHMP, Genzyme, Kynamro, Sanofi

Genzyme has expressed frustration at the CHMP’s negative opinion of its novel drug Kynamro, and plans to ask it to …

Signifor approved in US

December 17, 2012 Sales and Marketing Cushing's, Novartis, Signifor

Novartis’ injection Signifor has been approved by the FDA to treat Cushing’s disease, a rare but serious endocrine disorder affecting …
The Gateway to Local Adoption Series

Latest content